Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
The Magnum Ice Cream Company N.V. (TMICC or the Company) DIRECTOR DECLARATION The Magnum Ice Cream Company, as previously announced, confirms that Josh Frank will join the Board as a Non-Executive...
-
TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BL6K5J42 Issuer Name ENDEAVOUR MINING PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or...
-
1. märtsil kanti äriregistrisse AS Inbank ja Inbank Ventures OÜ ühinemine. Sellega on ühinemine lõpule viidud. Ühinemise tulemusena on Inbank Ventures OÜ õigusjärglaseks AS Inbank ning Inbank...
-
In February 2026, AS Tallink Grupp transported 364,894 passengers, representing a 5.0% increase compared to February 2025. The number of cargo units increased by 9.2% to 19,777 and the number of...
-
Progress on share buyback programme ING announced today that, as part of our €1.1 billion share buyback programme announced on 30 October 2025, in total 2,528,615 shares were repurchased during the...
-
(Artikel 14, eerste lid van de wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen) Samenvatting van de kennisgeving(en) KBC Groep NV ontving op 27 februari 2026 een...
-
AS Tallink Grupp vedas 2026. aasta veebruaris 364 894 reisijat, mis on 5,0% võrra rohkem kui 2025. aasta veebruaris. Veetud kaubaveoühikute arv suurenes 9,2% võrra 19 777 ühikuni ning veetud reisijate...
-
In February 2026, AS Tallink Grupp transported 364,894 passengers, representing a 5.0% increase compared to February 2025. The number of cargo units increased by 9.2% to 19,777 and the number of...
-
Disclosure of trading in own shares occurred from February 23 to February 27, 2026 Puteaux, March 3, 2026 In accordance with the regulations on share buybacks, in particular Regulation (EU)...
-
The Lancet Microbe publishes SNIPR001 Phase 1: safe, gut‑restricted, microbiome stable; Phase 1b HSCT trial >50% enrolled.